Last updated on February 2020

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children Known or Suspected to be Caused by Susceptible Gram-positive Organisms Including MRSA

Find a site near you

Start Over

Southbay Pharma Research

La Palma, CA United States
  Connect »

Revival Research

Doral, FL United States
  Connect »

Global Research Holdings, LLC

Panama City, FL United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

Children's Mercy Kansas City

Kansas City, KS United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

The Clinical Trial Center

Jenkintown, PA United States
  Connect »

Hospital Sant Joan de D u

Esplugues de Llobregat, Spain
  Connect »

Hospital Universitario Donostia

Donostia-San Sebastian, Spain
  Connect »

PE PMC Acinus

Kropyvnytskyi, Ukraine
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.